Page last updated: 2024-08-24

tenofovir and Pancreatitis

tenofovir has been researched along with Pancreatitis in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (66.67)	29.6817
2010's	1 (11.11)	24.3611
2020's	2 (22.22)	2.80

Authors

Authors	Studies
Goffard, JC; Henrard, S; Noure, L; Simeni Njonnou, SR	1
Cattaneo, D; Filice, C; Gervasoni, C; Riva, A	1
Yoganathan, K	1
Bettocchi, D; Consales, G; Durval, A; Luzzio, MG; Zamidei, L	1
Callens, S; Colebunders, R; De Schacht, C; Huyst, V	1
Blanchard, JN; Canas, A; King, K; Lonergan, JT; Wohlfeiler, M	1
Burger, D; Clotet, B; Galindos, MJ; Gel, S; Miralles, C; Moltó, J; Muñoz-Moreno, JA; Negredo, E; Pedrol, E; Puig, J; Ribera, E; Rodriguez Fumaz, C; Rodríguez, E; Ruiz, L; Viciana, P; Videla, S	1
Fulco, PP; Higginson, RT; Kirian, MA	1

Trials

2 trial(s) available for tenofovir and Pancreatitis

Article	Year
Tenofovir poses risk with didanosine. AIDS patient care and STDs, 2003, Volume: 17, Issue:6 Topics: Adenine; Anti-HIV Agents; Contraindications; Didanosine; Drug Administration Schedule; Humans; Organophosphonates; Organophosphorus Compounds; Pancreatitis; Tenofovir	2003
Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach. Antiviral therapy, 2004, Volume: 9, Issue:3 Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Chemical and Drug Induced Liver Injury; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Nevirapine; Organophosphonates; Pancreatitis; Patient Compliance; Quality of Life; RNA, Viral; Tenofovir	2004

Article

Year

Tenofovir poses risk with didanosine.

AIDS patient care and STDs, 2003, Volume: 17, Issue:6

Topics: Adenine; Anti-HIV Agents; Contraindications; Didanosine; Drug Administration Schedule; Humans; Organophosphonates; Organophosphorus Compounds; Pancreatitis; Tenofovir

2003

Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach.

Antiviral therapy, 2004, Volume: 9, Issue:3

Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Chemical and Drug Induced Liver Injury; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Nevirapine; Organophosphonates; Pancreatitis; Patient Compliance; Quality of Life; RNA, Viral; Tenofovir

2004

Other Studies

7 other study(ies) available for tenofovir and Pancreatitis

Article	Year
Severe rhabdomyolysis and acute asymptomatic pancreatitis following the concomitant use of Biktarvy in the setting of hyperosmolar diabetic crisis. BMJ case reports, 2020, Jul-01, Volume: 13, Issue:7 Topics: Adenine; Alanine; Anti-HIV Agents; Cholangiopancreatography, Magnetic Resonance; Diabetes Mellitus; Drug Combinations; Emtricitabine; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Insulin; Male; Middle Aged; Pancreatitis; Piperazines; Pyridones; Rhabdomyolysis; Tenofovir	2020
Bictegravir/emtricitabine/tenofovir alafenamide-induced acute pancreatitis: a case report. International journal of STD & AIDS, 2020, Volume: 31, Issue:10 Topics: Acute Disease; Adenine; Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Lipase; Male; Pancreas; Pancreatitis; Piperazines; Pyridones; Tenofovir; Ultrasonography	2020
Long-term suppressive therapy for pulmonary aspergilloma in an immunocompromised man with AIDS. Is it always necessary? International journal of STD & AIDS, 2009, Volume: 20, Issue:6 Topics: Adenine; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Aspergillosis; Didanosine; Drug Administration Schedule; Drug Interactions; Fatal Outcome; HIV Infections; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Middle Aged; Organophosphonates; Pancreatitis; Radiography; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome	2009
Hyperlipidemic acute pancreatitis: a possible role of antiretroviral therapy with entecavir. Minerva anestesiologica, 2011, Volume: 77, Issue:10 Topics: Abdominal Pain; Acute Disease; Adenine; Adult; Alcoholism; Antiretroviral Therapy, Highly Active; Critical Care; Diabetes Mellitus, Type 2; Fever; Guanine; Hepatitis B, Chronic; Humans; Hyperlipidemias; Hypertriglyceridemia; Male; Organophosphonates; Pancreatitis; Plasmapheresis; Reverse Transcriptase Inhibitors; Tenofovir; Tomography, X-Ray Computed; Triglycerides	2011
Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment. The Journal of infection, 2003, Volume: 47, Issue:2 Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Didanosine; Drug Interactions; Female; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Pancreatitis; Ritonavir; Stavudine; Tenofovir	2003
Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected]. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Sep-01, Volume: 37, Issue:5 Topics: Adenine; Adult; Didanosine; Drug Interactions; Fatal Outcome; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pancreatitis; Tenofovir	2003
Acute onset of pancreatitis with concomitant use of tenofovir and didanosine. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:10 Topics: Acute Disease; Adenine; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Pancreatitis; Tenofovir	2004